Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma

Bioengineered. 2021 Dec;12(1):7248-7262. doi: 10.1080/21655979.2021.1974328.

Abstract

RNA binding proteins (RBPs) play a pivotal role in various biological processes, and aberrant expression of RBPs is closely associated with tumorigenesis and progression. However, the role of RBPs in oral cavity squamous cell carcinoma (OCSCC) is yet unveiled. In this study, RNA sequences and clinical information of OCSCC samples were acquired from The Cancer Genome Atlas (TCGA) database. A total of 650 RBPs, with significantly different expression between healthy and OCSCC samples, were identified using the limma package. A prognostic model was constructed by Lasso-Cox analysis, resulting in the determination of 7 prognosis-related RBPs: ERMP1, RNASE3, ARL4D, CSRP2, ULK1, ZC3H12D, and RPS28. Based on the prognostic model, the risk scores of the OCSCC samples were calculated. The capability of the prognostic model was further evaluated using the receiver operating characteristic curve (ROC). The areas under ROC were 0.764, 0.771, and 0.809 at 1, 3 and 5-year respectively in the TCGA dataset. Internal and external validation showed satisfactory predictive capability for prognosis in OCSCC. In addition, a nomogram was created to graphically present the model. To further validate the analytical data, qRT-PCR was performed on normal and OCSCC cell lines. The mRNA expression of the 7 prognostic genes was in accordance with the analytical results. Functional analysis and gene connection networks were used to describe the biological functions and underlying interactions among the 7 prognostic genes Overall, 7 prognosis-related RBPs were identified, which could be used to predict clinical prognosis and to identify potential therapeutic targets for OCSCC.

Keywords: RNA-binding proteins (rbps); bioinformatics analysis; oral cavity squamous cell carcinoma (ocscc); overall survival; prognostic model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Computational Biology
  • Gene Expression Profiling
  • Humans
  • Mouth Neoplasms* / diagnosis
  • Mouth Neoplasms* / genetics
  • Mouth Neoplasms* / metabolism
  • Mouth Neoplasms* / mortality
  • Prognosis
  • RNA-Binding Proteins* / genetics
  • RNA-Binding Proteins* / metabolism
  • Squamous Cell Carcinoma of Head and Neck* / diagnosis
  • Squamous Cell Carcinoma of Head and Neck* / genetics
  • Squamous Cell Carcinoma of Head and Neck* / metabolism
  • Squamous Cell Carcinoma of Head and Neck* / mortality
  • Transcriptome / genetics

Substances

  • Biomarkers, Tumor
  • RNA-Binding Proteins

Grants and funding

This work was supported by the National Natural Science Foundation of China (No. 81470731) and the Natural Science Foundation of Guangdong Province (No. 2017A030313891);National Natural Science Foundation of China [81470731]; Natural Science Foundation of Guangdong Province [2017A030313891];